meta|Evidence - COVID-19
neutralizing antibody for ambulatory patients treatment comparison
vaccine booster (3rd dose) trial list | meta-analysis
vaccine booster (4th dose) trial list | meta-analysis
Vaccines effectiveness among children and adolescents trial list | meta-analysis
vaccines for omicron variant treatment comparison
anti-interleukin-6 (tocilizumab, sarilumab) in hospitalized patients treatment comparison
janus kinase inhibitors versus control (remdesivir or placebo) in hospitalized patients trial list | meta-analysis
CoronaVac all studies trial list | meta-analysis
vaccine effect on transmission treatment comparison
vaccine effect on transmission trial list | meta-analysis
vaccine efficacy of first dose treatment comparison
vaccine for beta variant (South Africa, B.1.351/501Y.V2 VOC) treatment comparison
vaccine for delta variant (B 1.617.2 variant, Indian VOC) treatment comparison
vaccine for gamma variant (P.1 variant, Brazil VOC) treatment comparison
vaccine for patient with solid cancer trial list | meta-analysis
vaccine for patients in haematological cancer trial list | meta-analysis
vaccine immunogenicity in autoimmune disease trial list | meta-analysis
vaccine in solid organ transplant recipients trial list | meta-analysis
vaccine safety - arterial thromboembolic events (ATE) treatment comparison
vaccine safety - various events treatment comparison
vaccine safety thrombocytopenia treatment comparison
vaccine safety venous thrombosis treatment comparison
vaccines for alpha variant (B.1.1.7 variant, UK VOC) treatment comparison
vaccines for B.1.351 variant (South Africa) treatment comparison
vaccines in dialysis patients trial list | meta-analysis
This project is supported by a grant of the French Ministry of Health (Hospital Clinical Research Program, PHRC-N) and self-funded by Hospices Civils de Lyon, CNRS UMR5558 LBBE University Lyon-1.
- About - Our approach - Credits Made with in Lyon - Contact us - Privacy policy -